Parameters affecting inhalation therapy adherence in elderly patients with chronic obstructive lung disease and asthma

Turan, Onur; Turan, Pakize Ayşe; Mirici, Arzu

doi:10.1111/ggi.12823

Cited by 38 publications

(32 citation statements)

References 28 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Reviewing the latest literature in the field of obstructive lung diseases, adherence to therapy in asthma and COPD was a frequent subject of research [4][5][6][7][8]. The results of the present study confirm that the GINA and GOLD guidelines are the essential factors determining the specialists' choice of therapy regimen.…”

Section: Discussionsupporting

confidence: 74%

“…The results of the present study confirm observation of poor adherence in COPD patients, what seems to be a serious clinical problem in all chronic respiratory diseases with hypoxemia. Cognitive dysfunction is frequently associated with a low socioeconomic status, another poor therapy adherence risk factor [4][5][6]. In the present study, the problem of non-compliance with the doctor's instructions was a frequent finding in less educated COPD and asthmatic patients.…”

Section: Discussionmentioning

confidence: 50%

See 1 more Smart Citation

Factors affecting the choice of therapeutic regimens in asthma and chronic obstructive pulmonary disease patients and patient adherence to the therapies prescribed

Nadziakiewicz¹,

Kurek²,

Almgren-Rachtan³

et al. 2018

pdia

View full text Add to dashboard Cite

Introduction: Chronic obstructive pulmonary disease (COPD) and asthma are the most common chronic respiratory diseases worldwide. At the moment, there is no information about the preferences of Polish specialists as regards the treatment of asthma and COPD or factors influencing the choice of particular treatment regimens. Aim: To determine the treatment options most commonly used by experienced pulmonologists and allergists for asthma and COPD and to identify the factors affecting the choice of a particular therapy. Material and methods: The survey included 224 doctors (pulmonologists and allergists) across Poland and concerned patients diagnosed with asthma (n = 4358) and COPD (n = 3062). Results: In the case of asthma, the most common therapy applied was inhaled glucocorticosteroids and long-acting β 2 agonists. According to 27.2% of doctors, combination therapy was used in 70-80% of patients while 23.7% declared that the proportion of patients receiving such a treatment exceeded 80%. In the case of COPD, anticholinergics were most frequently prescribed when inhaled glucocorticosteroids and long-acting β 2 agonists had proved insufficient. According to 21% of specialists, the percentage of patients treated so was 41-50%, while 19% declared the use of this treatment in 71-80% of patients. Conclusions: The most common treatments for asthma and COPD in Poland are inhaled glucocorticosteroids and long-acting β 2 agonists. The main factors influencing treatment decisions are the current GINA and GOLD recommendations as well as patients' age, comorbidities, and price of treatment.

show abstract

Section: Discussionsupporting

confidence: 74%

Section: Discussionmentioning

confidence: 50%

Factors affecting the choice of therapeutic regimens in asthma and chronic obstructive pulmonary disease patients and patient adherence to the therapies prescribed

Nadziakiewicz¹,

Kurek²,

Almgren-Rachtan³

et al. 2018

pdia

View full text Add to dashboard Cite

show abstract

“…In a study on 88 patients with COPD, Turan et al showed a positive correlation between declining of cognitive function, assessed by MMSE questionnaire, and suboptimal inhalation adherence, increasing hospitalizations and emergency visits [81]. In another study of 265 patients with COPD, adherence was measured using a tool incorporating sophisticated electronic devices to mark time and correctness of the technique; adherence over the study was 22.9% of what would be expected if all the doses had been taken correctly and on time, but more important adherence was negatively inluenced by impairment in cognitive function [82].…”

Section: Clinical Consequences Of An Afected Cognition; Measure Methodsmentioning

confidence: 99%

Neurocognitive Impairment as Systemic Effects of COPD

Oancea¹,

Tudorache²,

Tudorache³

2018

COPD - An Update in Pathogenesis and Clinical Management

View full text Add to dashboard Cite

Mild cognitive impairment (MCI), also known as incipient dementia, is characterized by the decline of cognitive function greater than expected for a certain age and educational level of the individual but not severe enough to interfere with their daily activities. However, this mild cognitive impairment afects several areas: visuospatial, memory, atention and luency and it is a signiicant concern because it decreases the quality of life and treatment adherence of these patients. On the other hand, evidence suggests that individuals with Chronic obstructive pulmonary disease (COPD) also present an important risk of falls: 46% of these patients experience a fall/year, sometimes with fatal consequences. Standard clinical balance measures can predict the risk of falls in this population. Moreover, increased inlammatory biomarkers are associated with the decrease of cognitive functions and a higher risk of falls in this population. Patients with COPD have a higher balance and cognitive impairment than their healthy peers Therefore, it is important to identify, assess and understand the relevance of these comorbidities in order to characterize the full clinical spectrum of COPD and adjust prevention strategies, given the devastating consequences of these problems.

show abstract

“…Dulohery et al (2015) found no associations between cognitive function and self-management abilities or quality of life; however, the authors underlined that, despite normal cognitive functioning, there is a negative influence of living alone on self-management abilities (Dulohery et al, 2015). Turan et al (2017) in their cross-sectional study, outlined that cognitive impairment had negative consequences on disease self-management: lower cognitive functioning could affect the correct inhalation device technique. Furthermore, they underlined that socioeconomic status, smoking, pulmonary symptoms, and admission to hospital could have an effect on the adherence to inhalation therapy (Turan et al, 2017).…”

Section: Impact Of Cognitive Decline and Psychosocial Distress On Dismentioning

confidence: 98%

“…Turan et al (2017) in their cross-sectional study, outlined that cognitive impairment had negative consequences on disease self-management: lower cognitive functioning could affect the correct inhalation device technique. Furthermore, they underlined that socioeconomic status, smoking, pulmonary symptoms, and admission to hospital could have an effect on the adherence to inhalation therapy (Turan et al, 2017). Greenlund et al (2016) underlined that cognitive deficits, in particular confusion and memory loss, may affect functional limitations in COPD patients, increasing the need for assistance in different domains such as safety, transportation, house-hold activities, and personal care.…”

Section: Impact Of Cognitive Decline and Psychosocial Distress On Dismentioning

confidence: 99%

From Mild Cognitive Impairment (MCI) to Dementia in Chronic Obstructive Pulmonary Disease. Implications for Clinical Practice and Disease Management: A Mini-Review

et al. 2020

View full text Add to dashboard Cite

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease characterized by partially irreversible chronic airflow limitation. Current literature highlights that COPD patients also have an increased risk to develop Mild Cognitive Impairment (MCI) and dementia. Chronic patients with cognitive impairment experience a worsening of health-related quality of life, mainly because it could affect treatment self-management, medication adherence and personal independence. Moreover, they also report high levels of anxiety and depression, which are associated with disease severity, poor quality of life, poor adherence to rehabilitation programs and difficulties in selfmanagement. In current literature, there is a lack of studies describing simultaneously the associations between cognitive impairment, dysfunctional psychosocial factors, self-management abilities and their impact on pharmacological/non-pharmacological adherence. Therefore, the aim of the present short review is to describe the implications of cognitive impairment and psychosocial factors for clinical practice and disease management in COPD patients. Due to the interaction of these factors on adherence to rehabilitation programs, self-management and rehabilitation completion, future research should investigate simultaneously the role of all these different aspects to individuate a specific clinical approach that might include specific screening tools to evaluate cognitive impairment and psychosocial difficulties. A timely specific evaluation, within an interdisciplinary approach, could help to implement a more individualized and personalized treatment.

show abstract

Parameters affecting inhalation therapy adherence in elderly patients with chronic obstructive lung disease and asthma

Cited by 38 publications

References 28 publications

Factors affecting the choice of therapeutic regimens in asthma and chronic obstructive pulmonary disease patients and patient adherence to the therapies prescribed

Factors affecting the choice of therapeutic regimens in asthma and chronic obstructive pulmonary disease patients and patient adherence to the therapies prescribed

Neurocognitive Impairment as Systemic Effects of COPD

From Mild Cognitive Impairment (MCI) to Dementia in Chronic Obstructive Pulmonary Disease. Implications for Clinical Practice and Disease Management: A Mini-Review

Contact Info

Product

Resources

About